| Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial BC Fellström, J Barratt, H Cook, R Coppo, J Feehally, JW de Fijter, ... The Lancet 389 (10084), 2117-2127, 2017 | 397 | 2017 |
| Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in chronically immunosuppressed adults following renal transplant: a phase 3, randomized clinical trial P Vink, JM Ramon Torrell, A Sanchez Fructuoso, SJ Kim, S Kim, ... Clinical Infectious Diseases 70 (2), 181-190, 2020 | 196 | 2020 |
| IgA nephropathy recurs early in the graft when assessed by protocol biopsy F Ortiz, R Gelpi, P Koskinen, A Manonelles, A Räisänen-Sokolowski, ... Nephrology Dialysis Transplantation 27 (6), 2553-2558, 2012 | 115 | 2012 |
| Health‐related quality of life after kidney transplantation: who benefits the most? F Ortiz, P Aronen, PK Koskinen, RK Malmström, P Finne, EO Honkanen, ... Transplant International 27 (11), 1143-1151, 2014 | 93 | 2014 |
| Predictors of renal allograft histologic damage progression F Ortiz, T Paavonen, T To, P Koskinen, P Finne, K Salmela, L Kyllo, C Gro, ... Journal of the American Society of Nephrology 16 (3), 817-824, 2005 | 75 | 2005 |
| Biochemical pathways of breath ammonia (NH3) generation in patients with end-stage renal disease undergoing hemodialysis W Chen, S Laiho, O Vaittinen, L Halonen, F Ortiz, C Forsblom, PH Groop, ... Journal of breath research 10 (3), 036011, 2016 | 63 | 2016 |
| Oral health in patients with renal disease: a longitudinal study from predialysis to kidney transplantation KM Nylund, JH Meurman, AM Heikkinen, JO Furuholm, F Ortiz, ... Clinical oral investigations 22, 339-347, 2018 | 59 | 2018 |
| Oral health and mortality in patients with chronic kidney disease H Ruokonen, K Nylund, J Furuholm, JH Meurman, T Sorsa, K Kotaniemi, ... Journal of Periodontology 88 (1), 26-33, 2017 | 55 | 2017 |
| Association of the salivary triggering receptor expressed on myeloid cells/its ligand peptidoglycan recognition protein 1 axis with oral inflammation in kidney disease KM Nylund, H Ruokonen, T Sorsa, AM Heikkinen, JH Meurman, F Ortiz, ... Journal of periodontology 89 (1), 117-129, 2018 | 50 | 2018 |
| Oral symptoms and oral health-related quality of life in patients with chronic kidney disease from predialysis to posttransplantation H Ruokonen, K Nylund, JH Meurman, AM Heikkinen, J Furuholm, T Sorsa, ... Clinical oral investigations 23, 2207-2213, 2019 | 38 | 2019 |
| Decreased kidney graft survival in low immunological risk patients showing inflammation in normal protocol biopsies F Ortiz, R Gelpi, I Helanterä, E Melilli, E Honkanen, O Bestard, JM Grinyo, ... PLoS One 11 (8), e0159717, 2016 | 28 | 2016 |
| Implementation of a transition model to adult care may not be enough to improve results: national study of kidney transplant recipients S Kosola, E Ylinen, P Finne, K Rönnholm, F Ortiz Clinical Transplantation 33 (1), e13449, 2019 | 27 | 2019 |
| Polyomavirus BK and JC infections in well matched Finnish kidney transplant recipients I Helanterä, F Ortiz, E Auvinen, A Räisänen‐Sokolowski, M Lappalainen, ... Transplant International 22 (7), 688-693, 2009 | 26 | 2009 |
| Long-term mortality after kidney transplantation in a nationwide cohort of patients with type 1 diabetes in Finland F Ortiz, V Harjutsalo, I Helanterä, M Lempinen, C Forsblom, PH Groop Diabetes Care 42 (1), 55-61, 2019 | 21 | 2019 |
| Is Cystatin C more sensitive than creatinine in detecting early chronic allograft nephropathy? F Ortiz, A Harmoinen, T Paavonen, P Koskinen, C Grönhagen-Riska, ... Clinical nephrology 70 (1), 18-25, 2008 | 18 | 2008 |
| Timing and value of protocol biopsies in well‐matched kidney transplant recipients–a clinical and histopathologic analysis I Helanterä, F Ortiz, H Helin, A Räisänen‐Sokolowski, E Honkanen, ... Transplant International 20 (11), 982-990, 2007 | 17 | 2007 |
| Impact of glucose metabolism abnormalities on histopathological changes in kidney transplant protocol biopsies I Helanterä, F Ortiz, A Räisänen‐Sokolowski, P Koskinen Transplant International 23 (4), 374-381, 2010 | 16 | 2010 |
| Letermovir treatment for CMV infection in kidney and pancreas transplantation: A valuable option for complicated cases F Ortiz, M Lempinen, S Aaltonen, N Koivuviita, I Helanterä Clinical Transplantation 36 (2), e14537, 2022 | 13 | 2022 |
| Simultaneous BK Polyomavirus (BKPyV)-associated nephropathy and hemorrhagic cystitis after living donor kidney transplantation I Helanterä, HH Hirsch, M Wernli, F Ortiz, M Lempinen, ... Journal of Clinical Virology 76, 4-7, 2016 | 11 | 2016 |
| High-level JCPyV viruria after kidney transplantation—Clinical and histopathological findings I Helanterä, HH Hirsch, E Auvinen, L Mannonen, M Nummi, M Wernli, ... Journal of Clinical Virology 85, 75-79, 2016 | 10 | 2016 |